Probiotics in the Treatment of Asthma and Allergy

Part of the Allergy Frontiers book series (ALLERGY, volume 6)


The prevalence of allergies, diabetes, Inflammatory Bowel Disease and other “immunologically mediated diseases of affluence” has increased progressively, particularly over the last 50 years. Over this time there has been growing recognition of the contributing role of declining microbial burden (the “hygiene hypothesis”). There has also been intense interest in the health benefits of dietary supplements (probiotic and prebiotic) that promote favourable colonisation. These two distinct, but rapidly converging, areas of research have emphasised the need to understand, and ultimately to manipulate, our physiological interactions with commensal microbiota.

According to the “hygiene hypothesis”, an apparent decline in microbial exposure during early childhood is one of the most plausible causes of the escalating rates of allergic disease. Epidemiological support for this hypothesis has been progressively consolidated by a growing understanding of effects of microbial factors on immune development. While this story began with allergic disorders, autoimmune conditions (such as type I diabetes and inflammatory bowel disease) are now being increasingly included in these models. It is proposed that the underlying concepts of immune regulation by microbes are similar for several immunologi-cally mediated diseases, which have also been considered as “microbial deficiency syndromes” [1].


Atopic Dermatitis Allergic Disease Allergy Clin Immunol Lactobacillus Rhamnosus Germ Free Mouse 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rook GA, Stanford JL (1998) Give us this day our daily germs. Immunol Today 19:113–116.CrossRefPubMedGoogle Scholar
  2. 2.
    Gerrard J, Geddes C, Reggin P, Gerrard C, Horne S (1976) Serum IgE levels in white and metis communities in Saskatchewan. Ann Allergy 37:91–100.PubMedGoogle Scholar
  3. 3.
    Strachan D (1989) Hay fever, hygiene and household size. Brit Med J 299:1259–1256.CrossRefPubMedGoogle Scholar
  4. 4.
    Böttcher MF, Jenmalm MC, Voor T, Julge K, Holt PG, Björkstén B (2006) Cytokine responses to allergens during the first 2 years of life in Estonian and Swedish children. Clin Exp Allergy 36:619–628.CrossRefPubMedGoogle Scholar
  5. 5.
    Holt PG, Macaubas C (1997) Development of long term tolerance versus sensitisation to environmental allergens during the perinatal period. Curr Opin Immunol 9:782–787.CrossRefPubMedGoogle Scholar
  6. 6.
    Thornton CA, Upham JW, Wikstrom ME, Holt BJ, White GP, Sharp MJ, Sly PD, Holt PG (2004) Functional maturation of CD4+CD25+CTLA4+CD45RA+ T regulatory cells in human neonatal T cell responses to environmental antigens/allergens. J Immunol 173:3084–3092.PubMedGoogle Scholar
  7. 7.
    Prescott SL, Macaubas C, Smallacombe T, Holt BJ, Sly PD, Holt PG (1999) Development of allergen-specific T-cell memory in atopic and normal children. Lancet 353:196–200.CrossRefPubMedGoogle Scholar
  8. 8.
    Ng T, Holt P, Prescott S (2002) Cellular immune responses to ovalbumin and house dust mite in egg-allergic children. Allergy 57:207–214.CrossRefPubMedGoogle Scholar
  9. 9.
    Smart J, Kemp A (2002) Increased Th1 and Th2 allergen-induced cytokine responses in children with atopic disease. Clin Exp Allergy 32:796–802.CrossRefPubMedGoogle Scholar
  10. 10.
    Stene LC, Nafstad P (2001) Relation between occurrence of type 1 diabetes and asthma. Lancet 257:607–608.CrossRefGoogle Scholar
  11. 11.
    Matricardi PM, Rosmini F, Panetta V, Ferrigno L, Bonini S (2002) Hay fever and asthma in relation to markers of infection in the United States. J Allergy Clin Immunol 110:381–387.CrossRefPubMedGoogle Scholar
  12. 12.
    Björkstén B (2004) Effects of intestinal microflora and the environment on the development of asthma and allergy. Springer Semin Immunopathol 25:257–270.CrossRefPubMedGoogle Scholar
  13. 13.
    Benn CS, Melbye M, Wohlfahrt J, Bjorksten B, Aaby P (2004) Cohort study of sibling effect, infectious diseases, and risk of atopic dermatitis during first 18 months of life. BMJ 328:1223–1230.CrossRefPubMedGoogle Scholar
  14. 14.
    Martinez FD (2001) The coming-of-age of the hygiene hypothesis. Respir Res 2:129–132.CrossRefPubMedGoogle Scholar
  15. 15.
    Hooper L, Gordon J (2001) Commensal host-bacterial relationships in the gut. Science 292:1115–1118.CrossRefPubMedGoogle Scholar
  16. 16.
    Bäckhed F, Ley R, Sonnenburg J, Peterson D, Gordon J (2007) Host-bacterial mutualism in the human intestine. Science 307:1915–1920.CrossRefGoogle Scholar
  17. 17.
    Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, Gordon JI, Relman DA, Fraser-Liggett CM, Nelson KE (2006) Metagenomic analysis of the human distal gut micro-biome. Science 312:1355–1359.CrossRefPubMedGoogle Scholar
  18. 18.
    Zoetendal EG, Akkermans AD, De Vos WM (1998) Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol 64:3854–3859.PubMedGoogle Scholar
  19. 19.
    Zoetendal EG, Ben-Amor K, Akkermans AD, Abee T, de Vos WM (2001) DNA isolation protocols affect the detection limit of PCR approaches of bacteria in samples from the human gastrointestinal tract. Syst Appl Microbiol 24:405–410.CrossRefPubMedGoogle Scholar
  20. 20.
    Björkstén B (2005) Genetic and environmental risk factors for the development of food allergy. Curr Opin Allergy Clin Immunol 5:249–253.CrossRefPubMedGoogle Scholar
  21. 21.
    Moreau MC, Coste M, Gaboriau V, Dubuquoy C (1995) Oral tolerance to ovalbumin in mice: effect of some paramters on the induction and persistence of the suppression of systemic IgE and IgG antibody responses. Adv Exp Med Biol 371B:1229–1234.PubMedGoogle Scholar
  22. 22.
    Sudo N, Sawamura S-A, Tanaka K, Aiba Y, Kubo C, Koga Y (1997) The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 159:1739–1745.PubMedGoogle Scholar
  23. 23.
    Demengeot J, Zelenay S, Moraes-Fontes MF, Caramalho I, Coutinho A (2006) Regulatory T cells in microbial infection. Springer Semin Immunopathol 28:41–50.CrossRefPubMedGoogle Scholar
  24. 24.
    Wills-Karp M, Santeliz J, Karp CL (2001) The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 1:69–75.CrossRefPubMedGoogle Scholar
  25. 25.
    Blumer N, Herz U, Wegmann M, Renz H (2005) Prenatal lipopolysaccharide-exposure prevents allergic sensitisation and airway inflammation, but not airway responsiveness in a murine model of experimental asthma. Clin Exp Allergy 35:397–402.CrossRefPubMedGoogle Scholar
  26. 26.
    Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, Martinez FD (1999) A polymorphism in the 5 ′ -flanking region of the CD14 gene is associated with circulating soluble CD14 levels with total serum IgE. Am J Respir Cell Mol Biol 20:976–983.PubMedGoogle Scholar
  27. 27.
    Eder W, Klimecki W, Yu L, von Mutius E, Riedler J, Braun-Fahrlander C, Nowak D, Martinez FD (2004) Toll-like receptor 2 as a major gene for asthma in children of European farmers. J Allergy Clin Immunol 113:482–488.CrossRefPubMedGoogle Scholar
  28. 28.
    Zuany-Amorim C, Sawicka E, Manlius C, Le Moine A, Brunet LR, Kemeny DM, Bowen G, Rook G, Walker C (2002) Suppression of airway eosinophilia by killed Mycobacterium vac-cae -induced allergen-specific regulatory T-cells. Nat Med 8:625–629.CrossRefPubMedGoogle Scholar
  29. 29.
    Di Giacinto C, Marinaro M, Sanchez M, Strober W, Boirivant M (2005) Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J Immunol 174:3237–3246.PubMedGoogle Scholar
  30. 30.
    Lammers KM, Brigidi P, Vitali B, Gionchetti P, Rizzello F, Caramelli E, Matteuzzi D, Campieri M (2003) Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol 38:165–172.CrossRefPubMedGoogle Scholar
  31. 31.
    Bowman L, Holt P, Björkstén. Immune regulation of the newborn using germ-free and conventional dendritic cells. In: World Immunology Congress 2001; abs 541, Stockholm, 2001.Google Scholar
  32. 32.
    Björkstén B, Sepp E, Julge K, Voor T, Mikelsaar M (2001) Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 108:516–520.CrossRefPubMedGoogle Scholar
  33. 33.
    Sepp E, Julge K, Mikelsaar M, Björkstén B (2005) Intestinal microbiota and immunoglobulin E responses in 5-year-old Estonian children. Clin Exp Allergy 35:1141–1146.CrossRefPubMedGoogle Scholar
  34. 34.
    Sepp E, Julge K, Vasar M, Naaber P, Björkstén B, Mikelsaar M (1997) Intestinal microflora of Estonian and Swedish infants. Acta Paediatr 86:956–961.CrossRefPubMedGoogle Scholar
  35. 35.
    Nicolai T, Bellach B, Mutius E V, Thefeld W, Hoffmeister H (1997) Increased prevalence of sensitization against aeroallergens in adults in West compared with East Germany. Clin Exp Allergy 27:886–892.CrossRefPubMedGoogle Scholar
  36. 36.
    Allen S, Okoko B, Martinez E, Gregorio G, Dans L (2004) Probiotics for treating infectious diarrhoea. Cochrane Database Syst Rev 2:CD003048.PubMedGoogle Scholar
  37. 37.
    D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ (2002) Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. Brit Med J 324:1361–1364.CrossRefPubMedGoogle Scholar
  38. 38.
    Weizman Z, Asli G, Alsheikh A (2005) Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 115:5–9.PubMedGoogle Scholar
  39. 39.
    Johnston B, Supina A, Vohtra S (2006) Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials. Can Med Assoc J 175:377–383.CrossRefGoogle Scholar
  40. 40.
    Majamaa H, Isolauri E (1997) Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 99:179–185.CrossRefPubMedGoogle Scholar
  41. 41.
    Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S (2000) Probiotics in the management of atopic eczema. Clin Exp Allergy 30:1604–1610.CrossRefPubMedGoogle Scholar
  42. 42.
    Viljanen M, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Kuitunen M (2005) Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 60:494–500.CrossRefPubMedGoogle Scholar
  43. 43.
    Viljanen M, Kuitunen M, Haahtela T, Juntunen-Backman K, Korpela R, Savilahti E (2005) Probiotic effects on faecal inflammatory markers and on faecal IgA in food allergic atopic eczema/dermatitis syndrome infants. Pediatr Allergy Immunol 16:65–71.CrossRefPubMedGoogle Scholar
  44. 44.
    Rosenfeldt V, Benfeldt E, Nielsen SD, Michaelsen KF, Jeppesen DL, Valerius NH, Paerregaard A (2003) Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 111:389–395.CrossRefPubMedGoogle Scholar
  45. 45.
    Sistek D, Kelly R, Wickens K, Stanley T, Fitzharris P, Crane J (2006) Is the effect of probiotics on atopic dermatitis confined to food sensitized children? Clin Exp Allergy. 36:629–633.CrossRefPubMedGoogle Scholar
  46. 46.
    Weston S, Halbert A, Richmond P, Prescott SL (2005) Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child 90:892–897.CrossRefPubMedGoogle Scholar
  47. 47.
    Brouwer ML, Wolt-Plompen SA, Dubois AE, van der Heide S, Jansen DF, Hoijer MA, Kauffman HF, Duiverman EJ (2006) No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin Exp Allergy 36:899–906.CrossRefPubMedGoogle Scholar
  48. 48.
    Prescott SL, Dunstan JA, Hale J, Breckler L, Lehmann H, Weston S, Richmond P (2005) Clinical effects of probiotics are associated with increased interferon-gamma responses in very young children with atopic dermatitis. Clin Exp Allergy 35:1557–1564.PubMedGoogle Scholar
  49. 49.
    Pohjavuori E, Viljanen M, Korpela R, Kuitunen M, Tiittanen M, Vaarala O, Savilahti E (2004) Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy. J Allergy Clin Immunol 114:131–136.CrossRefPubMedGoogle Scholar
  50. 50.
    Viljanen M, Pohjavuori E, Haahtela T, Korpela R, Kuitunen M, Sarnesto A, Vaarala O, Savilahti E (2005) Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome. J Allergy Clin Immunol 115:1254–1259.CrossRefPubMedGoogle Scholar
  51. 51.
    Rosenfeldt V, Benfeldt E, Valerius NH, Paerregaard A, Michaelsen KF (2004) Effect of pro-biotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J Pediatr 145:612–616.CrossRefPubMedGoogle Scholar
  52. 52.
    Helin T, Haahtela S, Haahtela T (2002) No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study. Allergy 57:243–246.CrossRefPubMedGoogle Scholar
  53. 53.
    Wang MF, Lin HC, Wang Y Y, Hsu CH (2004) Treatment of perennial allergic rhinitis with lactic acid bacteria. Pediatr Allergy Immunol 15:152–158.CrossRefPubMedGoogle Scholar
  54. 54.
    Xiao JZ, Kondo S, Yanagisawa N, Takahashi N, Odamaki T, Iwabuchi N, Miyaji K, Iwatsuki K, Togashi H, Enomoto K, Enomoto T (2006) Probiotics in the treatment of Japanese cedar pollinosis: a double-blind placebo-controlled trial. Clin Exp Allergy 36:1425–1435.CrossRefPubMedGoogle Scholar
  55. 55.
    Xiao JZ, Kondo S, Yanagisawa N, Takahashi N, Odamaki T, Iwabuchi N, Iwatsuki K, Kokubo S, Togashi H, Enomoto K, Enomoto T (2006) Effect of probiotic Bifidobacterium longum BB536 in relieving clinical symptoms and modulating plasma cytokine levels of Japanese cedar pollinosis during the pollen season. A randomized double-blind, placebo-controlled trial. J Investig Allergol Clin Immunol 16:86–93.PubMedGoogle Scholar
  56. 56.
    Xiao JZ, Kondo S, Yanagisawa N, Miyaji K, Enomoto K, Sakoda T, Iwatsuki K, Enomoto T (2007) Clinical efficacy of probiotic Bifidobacterium longum for the treatment of symptoms of Japanese cedar pollen allergy in subjects evaluated in an environmental exposure unit. Allergol Int 56:67–75.CrossRefPubMedGoogle Scholar
  57. 57.
    Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E (2001) Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357:1076–1079.CrossRefPubMedGoogle Scholar
  58. 58.
    Kalliomäki M, Salminen S, Poussa T, Arvilommi H, Isolauri E (2003) Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361:1869–1871.CrossRefPubMedGoogle Scholar
  59. 59.
    Kalliomäki M, Salminen S, Poussa T, Isolauri E (2007) Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 119:1019–1021.CrossRefPubMedGoogle Scholar
  60. 60.
    Matricardi P, Björkstén B, Bonini S, Bousquet J, Djukanovic R, Dreborg S, Gereda J, Malling H, Popov T, Raz E, Renz H, Wold A (2003) Microbial products in allergy prevention and therapy. Allergy 58:461–471.CrossRefPubMedGoogle Scholar
  61. 61.
    Taylor AL, Dunstan JA, Prescott SL (2007) Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitiza-tion in high-risk children: a randomized controlled trial. J Allergy Clin Immunol 119:184–191.CrossRefPubMedGoogle Scholar
  62. 62.
    Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Kuitunen M (2007) Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 119:192–198.CrossRefPubMedGoogle Scholar
  63. 63.
    Abrahamsson TR, Jakobsson T, Böttcher MF, Fredrikson M, Jenmalm MC, Björkstén B, Oldaeus G (2007) Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 119:1174–1180.CrossRefPubMedGoogle Scholar
  64. 64.
    Böttcher M, Abrahamsson T, Fredriksson M, Jakobsson T, Björkstén B (2008) Low breast milk TGF-b2 is induced by Lactobacillur reuteri supplemenation and associates with reduced risk of sensitisation during infancy. Pediatr Allergy Immunol 19:497–504CrossRefPubMedGoogle Scholar
  65. 65.
    Metchnikoff E. The prolongation of life. London: William Heinemann; 1907.Google Scholar
  66. 66.
    Sjögren YM, Jemalm MC, Böttcher MF, Björkstén B, Sverremark-Ekström E (2009) Altered early infant gut microbiota in children developing allergy up to 5 years of age. Clinical and Experimental allergy 39:518–526.CrossRefPubMedGoogle Scholar
  67. 67.
    Kopp MV, Hennemuth I, Heinzmann A, Urbanek R (2008) Randomized double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of lactobacillus GG supplementation. Pediatrics 121:850–856CrossRefGoogle Scholar
  68. 68.
    Arsanoglu S, Moro G, Schmitt J, Tandoi L, Rizzardi S, Boehm G (2008) Early dietary intervention with a mixture of prebiotic oligosacharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutr 138:1091–1095Google Scholar
  69. 69.
    van Hoffen E, Ruiter B, FaberJ, MRabet L, Knol EF, Stahl B, Arsanoglu S, Moro G, Boehm G, Garssen J (2009) A specific mixture of short-chain galoco-oligosacharides and long-chain fructooligosacharides induces a beneficial immunoglobulin profile in infants at high risk for allergy. Allergy 64:484–487CrossRefPubMedGoogle Scholar

Copyright information

© Springer 2010

Authors and Affiliations

  1. 1.Institute of Environmental Medicine, Division of Lung FysiologyKarolinska InstitutetStockholmSweden
  2. 2.School of Paediatrics and Child HealthUniversity of Western AustraliaPerthAustralia

Personalised recommendations